Kobayashi Hitomi | Division Of Rheumatology Itabashi Chuo Medical Center
スポンサーリンク
概要
関連著者
-
Kobayashi Hitomi
Division Of Rheumatology Itabashi Chuo Medical Center
-
Yokoe Isamu
Division Of Internal Medicine Itabashi Chuo Medical Center
-
Sato Hiroshi
Division Of Cardiology Tsukazaki Memorial Hospital
-
NISHIO Shinya
Division of Rheumatology, Itabashi Chuo Medical Center
-
Nishio Shinya
Division of Rheumatology, Itabashi Chuo Medical Center, Japan
-
Kobayashi Yasuyuki
Division of Cardiology, Gunma Prefectural Cardiovascular Center
-
Hirano Masaharu
Division Of Cardiology Hachioji Medical Center
-
Hirano Masaharu
Division Of Cardiology Tokyo Medical University
-
Yokoe Isamu
Division Of Rheumatology Itabashi Chuo Medical Center
-
Giles Jon
Division Of Rheumatology Johns Hopkins Arthritis Center Johns Hopkins University School Of Medicine
-
Hatanaka Yuki
Division Of Biological Science Graduate School Of Biology-oriented Science And Technology Kinki Univ
-
Kobayashi Yasuyuki
Department Of Cardiology Kanazawa Medical University
-
Kobayashi Yasuyuki
Department Of Radiology St. Marianna University School Of Medicine
-
ARINUMA Yoshiyuki
Division of Rheumatology, Teikyo University School of Medicine
-
Arinuma Yoshiyuki
Division Of Rheumatology Teikyo University School Of Medicine
-
Kobayashi Yasuyuki
Department Of Applied Chemistry Faculty Of Engineering Osaka University
-
Sato Hiroshi
Division Of Rheumatology Itabashi Chuo Medical Center
-
SATO Hiroshi
Division of Rheumatology, Itabashi Chuo Medical Center
-
Masuyama Atsushi
Division of Rheumatology, Itabashi Chuo Medical Center
-
Maniwa Keiichiro
Division of Rheumatology, Itabashi Chuo Medical Center
-
ISHIDA Tsuyoshi
Division of Pathology, Teikyo University School of Medicine
-
SUGIMURA Yusuke
Division of Rheumatology, Itabashi Chuo Medical Center
著作論文
- Cardiac magnetic resonance imaging abnormalities in patients with systemic lupus erythematosus : a preliminary report
- Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks
- Reply to : Comment on "Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks" by Yokoe et al
- A case of adult-onset Still's disease complicated by thrombotic thrombocytopenic purpura with retinal microangiopathy and rapidly fatal cerebral edema